249 related articles for article (PubMed ID: 16705949)
1. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.
Stabile A; Bertoni B; Ansuini V; La Torraca I; Sallì A; Rigante D
Eur Rev Med Pharmacol Sci; 2006; 10(2):53-9. PubMed ID: 16705949
[TBL] [Abstract][Full Text] [Related]
2. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
Tristano AG
Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in juvenile idiopathic arthritis.
Cortis E; Insalaco A
Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
[TBL] [Abstract][Full Text] [Related]
4. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
5. A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl.
Nakakura H; Ashida A; Matsumura H; Murata T; Nagatoya K; Shibahara N; Inoue T; Tamai H
Ther Apher Dial; 2009 Feb; 13(1):71-6. PubMed ID: 19379173
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome.
Grom AA; Villanueva J; Lee S; Goldmuntz EA; Passo MH; Filipovich A
J Pediatr; 2003 Mar; 142(3):292-6. PubMed ID: 12640378
[TBL] [Abstract][Full Text] [Related]
7. [A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis].
Imagawa T; Katakura S; Mori M; Aihara Y; Mitsuda T; Yokota S
Ryumachi; 1997 Jun; 37(3):487-92. PubMed ID: 9256033
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?
Behrens EM
Autoimmun Rev; 2008 Feb; 7(4):305-8. PubMed ID: 18295734
[TBL] [Abstract][Full Text] [Related]
9. [Multi-organ failure as first clinical sign of macrophage activation syndrome in childhood Still's disease].
López-Sánchez M; Rubio-López I; Obeso-González T; Teja-Barbero JL; Santidrián-Miguel JP; Peiro-Callizo E
An Pediatr (Barc); 2010 Oct; 73(4):194-8. PubMed ID: 20643591
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
[TBL] [Abstract][Full Text] [Related]
11. Retinal microangiopathy and rapidly fatal cerebral edema in a patient with adult-onset Still's disease and concurrent macrophage activation syndrome.
Gianella S; Schaer DJ; Schwarz U; Kurrer M; Heppner FL; Fehr J; Seebach JD
Am J Hematol; 2008 May; 83(5):424-7. PubMed ID: 18183612
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.
Hazen MM; Woodward AL; Hofmann I; Degar BA; Grom A; Filipovich AH; Binstadt BA
Arthritis Rheum; 2008 Feb; 58(2):567-70. PubMed ID: 18240215
[TBL] [Abstract][Full Text] [Related]
13. Etanercept in the treatment of macrophage activation syndrome.
Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA
J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic syndromes.
Janka GE
Blood Rev; 2007 Sep; 21(5):245-53. PubMed ID: 17590250
[TBL] [Abstract][Full Text] [Related]
15. Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan.
Chen HH; Kuo HC; Wang L; Yu HR; Shen JM; Kwang KP; Yang KD
J Microbiol Immunol Infect; 2007 Jun; 40(3):265-71. PubMed ID: 17639169
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients.
Mahlaoui N; Ouachée-Chardin M; de Saint Basile G; Neven B; Picard C; Blanche S; Fischer A
Pediatrics; 2007 Sep; 120(3):e622-8. PubMed ID: 17698967
[TBL] [Abstract][Full Text] [Related]
17. Hyperferritinemia as the diagnostic clue in life-threatening hemophagocytic lymphohistiocytosis.
Kerzel S; Zemlin M; Kömhoff M; Klaus G; Maier RF
Klin Padiatr; 2009 Sep; 221(5):318-21. PubMed ID: 19199227
[TBL] [Abstract][Full Text] [Related]
18. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.
Castillo L; Carcillo J
Pediatr Crit Care Med; 2009 May; 10(3):387-92. PubMed ID: 19325510
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
20. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R
J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
